Investor Summit Group's quarterly events feature live presentations with Q&A, 1-on-1 meetings, fireside chats and more. The upcoming summit will provide the opportunity to learn about relevant topics in the investment space with quality vetted investors and handpicked executives.
For more information visit:
Conference Website
- A2Z Smart Technologies Corp.
- Aclarion, Inc.
- AgriFORCE Growing Systems, Ltd.
- Akari Therapeutics
- American Rebel Holdings, Inc.
- Amesite Inc.
- Auddia Inc.
- Biomerica, Inc.
- Bionik Laboratories Corp.
- Boat Rocker Media Inc.
- Galleon Gold Corp.
- Inuvo, Inc.
A2Z Smart Technologies Corp. (NASDAQ: AZ) (TSXV: AZ)
A2Z Smart Technologies Corp. (NASDAQ: AZ)(TSXV: AZ) creates innovative solutions for complex challenges. A2Z's flagship product is the world's first proven-in-use mobile self-checkout shopping chart. With its user-friendly smart algorithm, touch screen, and computer-vision system, Cust2Mate streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply "pick & go", and bypass long cashier checkout lines. This results in a more efficient shopping experience for customers, less unused shelf-space and manpower requirements, and advanced command and control capabilities for store managers. For more information, visit the company's website: a2zas.com
Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW)
Aclarion, Inc. (NASDAQ: ACON) (NASDAQ: ACONW) is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information visit the company's website at: aclarion.com
AgriFORCE Growing Systems, Ltd. (NASDAQ: AGRI)
AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) is an AgTech company focused on the development and acquisition of crop production know-how and intellectual property augmented by advanced AgTech facilities and solutions. Looking to serve the global market, the Company's current focus is on North America, Europe and Asia. The AgriFORCE vision is to be a leader in delivering plant-based foods and products through advanced and sustainable AgTech solution platforms that make positive change in the world—from seed to table. The AgriFORCE goal: Clean. Green. Better. For more information visit the company's website at: www.agriforcegs.com
Akari Therapeutics (NASDAQ: AKTX)
Akari Therapeutics, plc (NASDAQ: AKTX) is a biotechnology company focused on developing advanced therapies for autoimmune and inflammatory diseases. Akari's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of C5 complement activation and leukotriene B4 (LTB4) activity. Akari's pipeline includes two Phase 3 clinical trial programs investigating nomacopan for bullous pemphigoid (BP) and pediatric hematopoietic stem cell transplant-related (HSCT) thrombotic microangiopathy (TMA), as well as pre-clinical research of long-acting PAS-nomacopan in geographic atrophy (GA). For more information visit the company's website at: www.akaritx.com
American Rebel Holdings, Inc. (NASDAQ: AREB) (NASDAQ: AREBW)
American Rebel Holdings, Inc. (NASDAQ: AREB) (NASDAQ: AREBW) operates primarily as a designer and marketer of branded safes and personal security and self-defense products. The Company also designs and produces branded apparel and accessories. For more information visit the company's website at: www.americanrebel.com
Amesite Inc. (NASDAQ: AMST)
Amesite Inc. (NASDAQ: AMST) an artificial intelligence driven platform and course designer, provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. Its customers include businesses, universities and colleges, K-12 schools, and non-profit organizations. The company was incorporated in 2017 and is headquartered in Detroit, Michigan. For more information, visit the company's website: amesite.com
Auddia Inc. (NASDAQ: AUUD)
Auddia Inc. (NASDAQ: AUUD) is reinventing how consumers engage with audio through the development of a proprietary AI platform for audio and innovative technologies for podcasts. Auddia offers two industry firsts-the ability to listen to any AM/FM radio station with added personalized content and no commercials, as well as podcasts with an interactive digital feed that supports deeper stories and delivers digital revenue to podcasters. Both offerings address large and rapidly growing audiences with strong purchase intent. For more information, visit the company's website: www.auddia.com
Bionik Laboratories Corp. (OTCQB: BNKL)
Bionik Laboratories Corp. (OTCQB: BNKL) is a robotics company focused on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. The Company has a portfolio of products focused on upper and lower extremity rehabilitation for stroke and other mobility-impaired patients, including three products on the market and three products in varying stages of development. For more information, visit the company's website: www.BIONIKlabs.com
Biomerica, Inc. (NASDAQ: BMRA)
Biomerica, Inc. (NASDAQ: BMRA) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point of care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica's primarily focus is on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development. For more information visit the company's website at: biomerica.com
Boat Rocker Media Inc. (TSX: BRMI)
Boat Rocker Media Inc. (TSX: BRMI) is the home for creative visionaries. An independent, integrated global entertainment company, Boat Rocker's purpose is to tell stories and build iconic brands across all genres and mediums. With offices around the world, Boat Rocker's creative and commercial capabilities include Scripted, Unscripted, and Kids & Family television production, distribution, brand & franchise management, a world-class animation studio, and talent management through Untitled Entertainment. A selection of Boat Rocker's projects include: Invasion (Apple TV+), American Rust (Showtime), Orphan Black (BBC AMERICA, CTV Sci-Fi Channel), Dear… (Apple TV+), Billie Eilish: The World's a Little Blurry (Apple TV+), The Next Step (BBC, Family Channel, CBC), Daniel Spellbound (Netflix), and Dino Ranch (Disney+, Disney Junior, CBC). For more information, visit the company's website: www.boatrocker.com
Galleon Gold Corp. (TSX-V: GGO)
Galleon Gold Corp. (TSX-V: GGO) is an exploration and development company focused on advancing the West Cache Gold Project in Timmins, Ontario. The project is situated approximately 7 km northeast of Pan American Silver's Timmins West Mine and 14 km southwest of Newmont's Hollinger Mine. Since acquiring the Project the Company has demonstrated significant resource growth while providing a strong valuation in its maiden Preliminary Economic Assessment. Permitting and baseline studies in support of a bulk sample are currently underway. Eric Sprott holds approximately 21% of the Company's outstanding common shares. For more information, visit the company's website at: www.galleongold.com
Inuvo, Inc. (NYSE American: INUV)
Inuvo, Inc. (NYSE American: INUV) is a market leader in Artificial Intelligence built for advertising. Its IntentKey AI solution is a first-of-its-kind proprietary and patented technology capable of identifying and actioning to the reasons WHYconsumers are interested in products, services, or brands, not WHO those consumers are. For more information visit the company's website at: www.inuvo.com
Khiron Life Sciences Corp. (OTC: KHRNF)
Khiron Life Sciences Corp. (OTC: KHRNF) is a leading vertically integrated international medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, UK, and Brazil and is positioned to commence sales in Mexico. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors. For more information visit the company's website at: investors.khiron.ca
Leet Technology Inc. (OTCQB: LTES)
Leet Technology Inc. (OTCQB: LTES) is an esports technology company that provides a platform for competitive gaming (including arcade games) in the fast-growing Southeast Asian markets with a community and mass market focus through its flagship product Matchroom and municipal end users. The Company's mission is delivering an end-to-end eSports & gaming ecosystem that enables registered users to play from anywhere at any time. It emphasizes catering to the general mass market over the niche professionals where the majority of market share and spending power is. Leet Technology Inc. leverages partnerships with ICT and OTT operators with cost efficient solutions that can enhance their bottom lines. For more information visit the company's website at: myleet.com
LogicMark, Inc. (NASDAQ: LGMK)
LogicMark, Inc. (NASDAQ: LGMK) provides personal emergency response systems (PERS), health communications devices and technologies to create a Connected Care Platform. The Company's devices give people the ability to receive care at home and confidence to age in place. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly into its medical alert pendant and providing this life-saving technology at a price point everyday consumers can afford. The Company's PERS technologies are sold through the United States Veterans Health Administration and dealers/distributors. LogicMark has been awarded a contract by the U.S. General Services Administration that enables the Company to distribute its products to federal, state, and local governments. For more information visit the company's website at: www.logicmark.com
LiveOne, Inc. (NASDAQ: LVO)
LiveOne, Inc. (NASDAQ: LVO) is a creator-first, music, entertainment and technology platform focused on delivering premium experiences and content worldwide through memberships and live and virtual events. As of April 1, 2022, the Company has accrued a paid and free membership base of over 2.23 million**, streamed over 2,900 artists, has a library of 30 million songs, 600 curated radio stations, nearly 270 podcasts/vodcasts, hundreds of pay-per-views, personalized merchandise, released music-related NFTs, and created a valuable connection between fans, brands, and bands. The Company's wholly-owned subsidiaries include Slacker Radio, React Presents, Gramophone Media, Palm Beach Records, Custom Personalization Solutions, LiveXLive, PPVOne and PodcastOne, which generates more than 2.48 billion downloads per year and 300+ episodes distributed per week across its stable of top-rated podcasts. LiveOne is available on iOS, Android, Roku, Apple TV, Amazon Fire, and through OTT, STIRR, and XUMO. For more information, visit the company's website: www.liveone.com
LiveToBeHappy, Inc. (OTC: CAVR)
LiveToBeHappy, Inc. (OTC: CAVR) is a vertically integrated platform company focused on developing and building lifestyle brands. The Company acquires undervalued assets and manages a diversified portfolio of technology, education, and real estate services companies. The LTBH mission is to build lives, not just places to live. For more information visit the company's website at: www.livetobehappy.com
MamaMancini's Holdings (NASDAQ: MMMB)
MamaMancini's Holdings, Inc. (NASDAQ: MMMB) strives to become the largest marketer and distributor of fresh, clean, easy to prepare foods in North America. MamaMancini's broad product portfolio consists of meatballs, meatloaf, sausages and pasta bowls with beef, turkey, chicken and pork varieties – as well as an assortment of chicken-based dishes, olives, savory products and salads through its T&L Creative Salads and Olive Branch subsidiaries. The Company owns a 24% interest in Chef Inspirational Foods, an innovative sales and marketing company that specializes in the prepared foods category. The Company's products are sold in over 45,000 locations nationwide, including at regional delis and well-known retailers such as Sam's Club, ALDI Markets, Schnuck Markets, Whole Foods, Publix, ShopRite, Stop & Shop, Costco and Albertsons – as well as through national distributors such as Sysco and United Natural Foods. The Company also maintains a direct-to-consumer presence on QVC. For more information, visit the company's website: www.mamamancinis.com
NextTech AR Solutions (OTCQB: NEXCF) (CSE: NTAR)
NextTech AR Solutions (OTCQB: NEXCF) (CSE: NTAR) is the engine accelerating the growth of the Metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the Metaverse. Their platform agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D Commerce, Education, Events, and Industrial Manufacturing, Nextech AR is in a unique position to meet the needs of the world's biggest brands and all Metaverse contributors. For more information, visit the company's website: www.Nextechar.com
Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH)
Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) is a seed-to-sale cannabinoid and nutraceutical manufacturer and research company that produces purposeful, natural pharmaceutical alternatives for consumers and pets. They manufacture and sell softgels, gummies, tinctures, sublingual tablets, patches, K-Tape, cosmetics, skin care and other topicals. Panacea was founded by Leslie Buttorff in 2017 as a woman-owned business. Panacea was formed to own and engage in creating disruptive healthcare and veterinary solutions with a specific focus on hemp. Their goals are to research, produce, and distribute products both domestically and internationally that target and treat major categories of medical conditions: pain, cancer, psychological, epilepsy, gastrointestinal, autoimmune, neurological, and sleep disorders. These categories include conditions that affect hundreds of millions of patients and animals worldwide. Their vision is to become the leading research and manufacturing cannabinoid and nutraceutical company (top 10 in terms of revenue and brand) in the U.S. and globally with a research arm focused on pre-clinical research in order to develop purposeful solutions for their human and animal customers. For more information, visit the company's website: panacealife.com
ProPhase Labs, Inc. (NASDAQ: PRPH)
ProPhase Labs, Inc. (NASDAQ: PRPH) is a diversified diagnostics, genomics and biotech company that seeks to leverage its CLIA lab services to provide whole genome sequencing and research direct to consumers and build a genomics data base to be used for further research. The Company continues to provide traditional CLIA molecular laboratory services, including COVID-19 testing. The Company also continues to operate a state-of-the-art contract manufacturing subsidiary and the TK Supplements line of dietary supplements, distributed in food, drug and mass stores throughout the country. For more information, visit the company's website: www.ProPhaseLabs.com
Rekor Systems, Inc. (NASDAQ: REKR)
Rekor Systems, Inc. (NASDAQ: REKR) is a trusted global authority on intelligent infrastructure providing innovative solutions that drive the world to be safer, smarter, and more efficient. As a provider of comprehensive, continuous, and real-time roadway intelligence, Rekor leverages AI, machine learning, and holistic data to support the intelligent infrastructure that is essential for smart mobility. With its disruptive technology, the Company delivers integrated solutions, actionable insights, and predictions that increase roadway safety. For more information, visit the company's website: www.rekor.ai
Reliance Global Group (NASDAQ: RELI) (NASDAQ: RELIW)
Reliance Global Group (NASDAQ: RELI) (NASDAQ: RELIW) is combining advanced technologies, with the personalized experience of a traditional insurance agency model. Reliance Global Group's growth strategy includes both an organic expansion, including through 5minuteinsure.com, as well as acquiring well managed, undervalued and cash flow positive insurance agencies. For more information, visit the company's website: www.relianceglobalgroup.com
Remark Holdings Inc. (NASDAQ: MARK)
Remark Holdings, Inc. (NASDAQ: MARK) delivers an integrated suite of AI solutions that enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. The company's easy-to-install AI products are being rolled out in various retail, public safety, and workplace applications. The company also owns and operates an e-commerce digital media property focused on a luxury beach lifestyle. The company's corporate headquarters and U.S. operations are based in Las Vegas, Nevada, and it also maintains operations in London, England, and Shanghai, China. The operations of the variable interest entities that the company consolidates are headquartered in Chengdu, China, with additional offices in Hangzhou. For more information, visit the company's website at: www.remarkholdings.com
SaverOne (NASDAQ: SVRE) (TASE: SVRE)
SaverOne is a technology company engaged in the design, development and commercialization of transportation safety solutions designed to save lives by preventing car accidents resulting from the use of mobile phones while driving. Their SaverOne system provides an advanced driver safety solution that can identify and monitor mobile phones located in the driver's vicinity and selectively block use of life-threatening applications. For more information, visit the company's website: saver.one
Sintana Energy Inc. (TSX-V: SEI)
Sintana Energy Inc. (TSX-V: SEI) is engaged in petroleum and natural gas exploration and development activities in Colombia's Magdalena Basin and five large, highly prospective, onshore and offshore petroleum exploration licenses in Namibia. Sintana's exploration strategy is to acquire, explore, develop and produce superior quality assets with substantial reserves potential. For more information, visit the company's website: www.sintanaenergy.com
SQL Technologies Corp. (NASDAQ: SKYX)
SQL Technologies Corp. (NASDAQ: SKYX) has a series of highly disruptive advanced-safe-smart platform technologies, with over 60 U.S. and global patents and patent pending applications. Their technologies place an emphasis on high quality and ease of use, while significantly enhancing both safety and lifestyle in homes and buildings. They believe that their products are a necessity in every room in both homes and other buildings in the U.S. and globally. For more information, visit the company's website: skyplug.com
Tonix Pharmaceuticals (NASDAQ: TNXP)
Tonix Pharmaceuticals (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Tonix's portfolio is composed of immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. Tonix's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-15001 which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. A Phase 1 study of TNX-1500 is expected to be initiated in the second half of 2022. Tonix's rare disease portfolio includes TNX-29002 for the treatment of Prader-Willi syndrome. TNX-2900 has been granted Orphan-Drug Designation by the FDA. Tonix's infectious disease pipeline includes a vaccine in development to prevent smallpox and monkeypox called TNX-8013, next-generation vaccines to prevent COVID-19, and an antiviral to treat COVID-19. Tonix's lead vaccine candidates for COVID-19 are TNX-1840 and TNX-18504, which are live virus vaccines based on Tonix's recombinant pox vaccine (RPV) platform. TNX-35005 (sangivamycin, i.v.solution) is a small molecule antiviral drug to treat acute COVID-19 and is in the pre-IND stage of development. TNX-102 SL6, (cyclobenzaprine HCl sublingual tablets), is a small molecule drug being developed to treat Long COVID, a chronic post-acute COVID-19 condition. Tonix expects to initiate a Phase 2 study in Long COVID in the second quarter of 2022. The Company's CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix's lead CNS candidate, TNX-102 SL, is in mid-Phase 3 development for the management of fibromyalgia with a new Phase 3 study launched in the second quarter of 2022. Finally, TNX-13007 is a biologic designed to treat cocaine intoxication that is expected to start a Phase 2 trial in the second quarter of 2022. TNX-1300 has been granted Breakthrough Therapy Designation by the FDA. For more information, visit the company's website: www.TonixPharma.com
Tower One Wireless Corp. (OTCQB: TOWTF)
Tower One Wireless Corp. (OTCQB: TOWTF) owns, develops, and operates build-to-suit multitenant communications structures in Canada, Colombia, Mexico, the United States, and Ecuador. Tower One Wireless focuses primarily on the construction of towers in municipalities where cellular coverage is limited or non-existent, and engages in the leasing of space on communications sites to mobile network operators. The company also provides tower-related services, including site acquisition, zoning and permitting, structural analysis, and construction. Tower One Wireless Corp. was founded in 2015 and is based in Vancouver, Canada. For more information, visit the company's website: toweronewireless.com
Trust Stamp Inc. (NASDAQ: IDAI)
Trust Stamp Inc. (NASDAQ: IDAI) is a global provider of AI-powered identity services for use in multiple sectors including banking and finance, regulatory compliance, government, real estate, communications, and humanitarian services. Its technology empowers organizations with advanced biometric identity solutions that reduce fraud, protect personal data privacy, increase operational efficiency, and reach a broader base of users worldwide through its unique data transformation and comparison capabilities. For more information visit the company's website at: truststamp.ai
Virios Therapeutics, Inc. (NASDAQ: VIRI)
Virios Therapeutics, Inc. (NASDAQ: VIRI) is a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, such as fibromyalgia ("FM"). Immune responses related to the activation of tissue resident Herpes Simplex Virus-1 ("HSV-1") have been postulated as a potential root cause triggering and/or sustaining chronic illnesses such as FM, irritable bowel disease ("IBS"), chronic fatigue syndrome and other functional somatic syndromes, all of which are characterized by waxing and waning symptoms with no obvious etiology. Their lead development candidate ("IMC-1") is a novel, proprietary, fixed dose combination of famciclovir and celecoxib designed to synergistically suppress HSV-1 replication, with the end goal of reducing virally promoted disease symptoms. Evidence of IMC-1's efficacy on a broad spectrum of FM outcome measures was previously demonstrated in a Phase 2a clinical trial. These trial results are suggestive that IMC-1 may represent a new and novel treatment for fibromyalgia. IMC-1 has been granted fast track designation by the FDA and is currently being tested in a multi-center, randomized, double-blind, placebo-controlled Phase 2b trial ("FORTRESS") designed to set the stage for registrational studies. The Company is led by an executive team highly experienced in the successful development and commercialization of novel therapies. For more information visit the company's website at: www.virios.com
Vitalhub Corp. (OTC: VHIBF)
Vitalhub Corp. (OTC: VHIBF) is software for Health and Human Services providers designed to simplify the user experience & optimize outcomes. VitalHub provides technology to Health and Human Services providers including; Hospitals, Regional Health Authorities, Mental Health, Long Term Care, Home Health, Community and Social Services. VitalHub solutions span the categories of Electronic Health Record (EHR), Case Management, Care Coordination, Patient Flow & Operational Visibility, and DOCit Mobile Apps. The Company has a robust two-pronged growth strategy, targeting organic growth opportunities within its product suite, and pursuing an aggressive M&A plan. Currently, VitalHub serves 275+ clients across Canada, USA, UK, Australia, Qatar, and Latvia. VitalHub is based in Toronto, Canada, with an offshore development hub in Sri Lanka. The Company is publicly traded on the TSX Venture Exchange under the symbol "VHI". For more information visit the company's website at: www.vitalhub.com
VolitionRx Limited (NYSE AMERICAN: VNRX)
VolitionRx Limited (NYSE AMERICAN: VNRX) is a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases, including some cancers and diseases associated with NETosis such as sepsis and COVID-19. Early diagnosis and monitoring have the potential to not only prolong the life of patients but also improve their quality of life. The tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid—an indication that disease is present. Volition is primarily focused on human diagnostics and monitoring, but also has a subsidiary focused on animal diagnostics and monitoring. Volition's research and development activities are centered in Belgium, with an innovation laboratory and an office in the U.S. and additional offices in London and Singapore. For more information visit the company's website at: volition.com
VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY)
VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) is the world leader in Proactive Digital Display™, which transforms retail and public spaces as well as place-based media networks with SaaS-based audience measurement and security software that uses artificial intelligence and machine learning. Its proprietary technology effectively integrates with other digital retail solutions, including QR codes and mobile applications. The firm is also recognized for its leadership role in the growing Store as a Medium movement that enables brands to reach customers when and where buying decisions are being made while producing a new revenue stream for retailers. For more information, visit the company's website: vsblty.net
Vyant Bio, Inc. (NASDAQ: VYNT)
Vyant Bio, Inc. (NASDAQ: VYNT) is an innovative biotechnology company focused on identifying unique biological targets and novel and repurposed therapeutics. Vyant Bio has built a platform of therapeutics seeking to treat neurodevelopmental and neurodegenerative diseases, with current programs targeting Rett Syndrome ("Rett"), CDKL5 Deficiency Disorders ("CDD"), and Parkinson's Disease. The Company's approach to drug discovery integrates human-derived biology with artificial intelligence and machine learning technologies to de-risk candidate selection, with the goal of improving the potential effectiveness of drugs discovered earlier in the development cycle. Vyant Bio's management believes that drug discovery needs to progressively shift to more efficient methods as the widely used models for predicting safe and effective drugs have under-performed, as evidenced by the significant time and cost of bringing novel drugs to market. By combining sophisticated data science capabilities with highly functional human cell derived disease models, Vyant Bio seeks to leverage its current ability to screen and test therapeutic candidates, and create a unique approach to assimilating data that supports decision making iteratively throughout the discovery phase of drug development to identify both novel and repurposed CNS therapeutic candidates. For more information, visit the company's website: www.vyantbio.com
Zomedica Corp. (NYSE American: ZOM)
Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica's mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit the company's website: www.ZOMEDICA.com